Itekhnoloji ye-G-MAB yobunini be-Sorrento, eyaqanjwa nguGqr. Ji, isekwe kusetyenziso lwe-RNA ekhutshelweyo yokukhulisa imimandla eguquguqukayo ye-antibody evela kubaxhasi abangaphezu kwama-600. 

Uhlalutyo olunzulu lwedatha ye-DNA yolandelelwano olunzulu lubonise ukuba ilayibrari ye-G-MAB iqulethe ngaphezu kwe-10 quadrillion (10).¹⁶) ulandelelwano olwahlukileyo lwe-antibody. Oku kuyenza ibe lelinye lawona mathala eencwadi makhulu akhusela abantu ngokupheleleyo kwishishini le-biopharmaceutical. Ukuza kuthi ga ngoku, i-Sorrento ichonge ngempumelelo izilwa-buhlungu zomntu ezichasene ne-100 enxulumene neklinikhi ephezulu ekujoliswe kuyo kwimpembelelo ye-oncogenic, kubandakanywa i-PD-1, i-PD-L1, i-CD38, i-CD123, i-CD47, i-VEGFR2, kunye ne-CCR2.

Ukuphumelela kakhulu ukuvavanya izinga lokubetha (i-100+ iithagethi ezifanelekileyo zeklinikhi zihlolwe).

• Ukwahlukana okuphezulu kakhulu (2 x 10¹⁶ Ulandelelwano olwahlukileyo lwe-antibody)
• Itekhnoloji yobunini (ukwandiswa kwe-RNA kulungiselelwa ukwenziwa kwethala leencwadi)

Ubunakho bokuVelisa:

• indawo ye-cGMP
• Gcwalisa/ukugqiba amandla
• Inkxaso epheleleyo yohlalutyo